Oakwood Capital Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-45,734
Closed -$6.37M 52
2019
Q2
$6.37M Sell
45,734
-889
-2% -$123K 2.73% 15
2019
Q1
$6.52M Buy
46,623
+1,550
+3% +$208K 2.73% 12
2018
Q4
$5.82M Buy
+45,073
New +$6.29M 2.73% 14
2015
Q1
Sell
-45,377
Closed -$4.75M 95
2014
Q4
$4.75M Buy
45,377
+1,825
+4% +$192K 1.35% 31
2014
Q3
$4.64M Buy
43,552
+1,658
+4% +$172K 1.35% 30
2014
Q2
$4.38M Buy
41,894
+3,262
+8% +$330K 1.32% 32
2014
Q1
$3.79M Sell
38,632
-155
-0.4% -$14.4K 1.25% 37
2013
Q4
$3.55M Buy
38,787
+350
+0.9% +$32.3K 1.18% 37
2013
Q3
$3.33M Buy
38,437
+1,425
+4% +$128K 1.22% 37
2013
Q2
$3.18M Buy
+37,012
New +$3.14M 1.26% 35

Other funds holding JNJ

Oakwood Capital Management's JNJ Position: Q3 2019 in Review

Oakwood Capital Management sold out of Johnson & Johnson (JNJ) in Q3 2019, closing a stake of 45,734 shares — an estimated $6.37M sold.

Oakwood Capital Management first reported a position in JNJ in Q2 2013 and held it in 10 quarters. The position peaked at $6.52M in Q1 2019. 2,724 funds tracked by Wall St. Rank hold JNJ as of Q3 2019.

  • Oakwood Capital Management reported no remaining Johnson & Johnson position as of Q3 2019 after selling out during the quarter.
  • Oakwood Capital Management sold 45,734 Johnson & Johnson shares in Q3 2019, an estimated $6.37M.
  • Oakwood Capital Management first reported a position in Johnson & Johnson in Q2 2013 and held it in 10 quarters.
  • Oakwood Capital Management's Johnson & Johnson position peaked at $6.52M in Q1 2019.
  • 2,724 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2019.

Based on Oakwood Capital Management's 13F filing for Q3 2019, filed 23 Oct 2019.